No CrossRef data available.
Article contents
Reviews in Health Law: Patenting Technology Instead of Identity
Published online by Cambridge University Press: 01 January 2021
Abstract
An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- JLME Column
- Information
- Copyright
- Copyright © American Society of Law, Medicine and Ethics 2004
References
Diamond v. Chakraberty, 447 U.S. 303.Google Scholar
Grisham, J., “New Rules for Gene Patents” Nature Biotechnology 18, no. 9 (2000): at 921; Gitter, D.M., “International Conflicts Over Patenting Human DNA Sequences in the United State and the European Union: An Argument for Compulsory Licensing and a Fair-Use Exemption,” New York University Law Review 76 (2001): at 1624; Pollack, A., “U.S. Hopes to Stem Rush Toward Patenting Genes,” The Patriot Ledger (Quincy, MA), June 29, 2002: at 18.Google Scholar
Grisham, , supra note 2, at 921.Google Scholar
Grisham, , supra note 2, at 921.Google Scholar
Grisham, , supra note 2, at 50.Google Scholar
Resnik, D. B., Owning the Human Genome; A Moral Analysis of DNA Patenting (Albany, NY: SUNY Press, 2004): at 51.Google Scholar
Resnik, , supra note 6, at 51.Google Scholar
Resnik, , supra note 6, at 155.Google Scholar
Resnik, , supra note 6, at 66.Google Scholar
Resnik, , supra note 6, at 66, 72.Google Scholar
Resnik, , supra note 6, at 67.Google Scholar
Resnik, , supra note 6, at 67.Google Scholar
Resnik, , supra note 6, at 73.Google Scholar
Resnik, , supra note 6, at 77.Google Scholar
Resnik, , supra note 6, at 78.Google Scholar
Resnik, , supra note 6,. at 78.Google Scholar
Resnik, , supra note 6,. at 81.Google Scholar
Resnik, , supra note 6, at 80.Google Scholar
Resnik, D. B., “DNA Patents and Human Dignity” Journal of Law, Medicine & Ethics 29, no. 2 (2001): 152–65.CrossRefGoogle Scholar
Resnik, , supra note 6, at 129.Google Scholar
Resnik, , supra note 6, at 196Google Scholar
Resnik, , supra note 6, at 196.Google Scholar
Resnik, , supra note 6, at 196.Google Scholar
Resnik, , supra note 6,. at 201.Google Scholar
Resnik, , supra note 6,. at 65.Google Scholar
Resnik, , supra note 6, at 65.Google Scholar
Resnik, , supra note 6, at 83–84.Google Scholar
Resnik, , supra note 6, at 197.Google Scholar
Resnik, , supra note 6, at 197.Google Scholar
Resnik, , supra note 6, at 200.Google Scholar
See, e.g., Pitcher, A.S., “Contrary to First Impression, Genes are Patentable: Should there be Limitations?” Journal of Health Care Law and Policy 6 (2003): at 284; Horn, M. E., “DNA Patenting and Access to Healthcare: Achieving the Balance Among Competing Interests,” Cleveland State Law Review 50 (2003): at 253; Lissy, N. A., “Patentability of Chemical and Biotechnology Inventions: A Discrepancy in Standards,” Washington University Law Quarterly 81 (2003): at 1069.Google Scholar